麻豆官网首页入口

Accessibility links

Skip to content
Accessibility Help

Home
News
Sport
Weather
iPlayer
Sounds
Bitesize
CBeebies
C麻豆官网首页入口
Food

Home
News
Sport
Weather
iPlayer
Sounds
Bitesize
CBeebies
C麻豆官网首页入口
Food

.sc-c-sounds-nav { position: relative; } .sc-c-sounds-nav__menu-button { display: none; } .sc-c-sounds-nav__items { max-height: 500px; visibility: visible; position: static; } .sc-c-sounds-nav__overlay { display: none; } @media screen and (max-width: 659px) { .sc-c-sounds-nav__wrapper { padding-bottom: 0px; } .sc-c-sounds-nav__wordmark-link { padding-bottom: 18px; } }

Sounds home page

Home
Music
Podcasts
My Sounds

Newsday - US approves first new Alzheimer's drug in 20 years - 麻豆官网首页入口 Sounds

From: Newsday

US approves first new Alzheimer's drug in 20 yearsUS approves first new Alzheimer's drug in 20 years

Available for over a year

Aducanumab targets the underlying cause of Alzheimer's rather than its symptoms

More episodes

Programme Website

Coming Up Next

听
now playing
Newsday
US approves first new Alzheimer's drug in 20 years
Aducanumab targets the underlying cause of Alzheimer's rather than its symptoms
3 mins
听

Cymraeg
Gaeilge
骋脿颈诲丑濒颈驳

Contacts, Privacy and Information
Help with Signing In
Newsletter

Explore the 麻豆官网首页入口

Home
News
Sport
Weather
iPlayer
Sounds
Bitesize
CBeebies
C麻豆官网首页入口
Food

Terms of Use
About the 麻豆官网首页入口
Privacy Policy
Cookies
Accessibility Help
Parental Guidance
Contact the 麻豆官网首页入口
Make an editorial complaint
麻豆官网首页入口 emails for you